AAAAAA

   
Results: 1-9 |
Results: 9
CYTOSINE-ARABINOSIDE, ETOPOSIDE AND ACLARUBICIN (AVA) FOR THE TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN ELDERLY PATIENTS
Authors: STAIB P LATHAN B KNOPPELSCHWARK S TESCH H VOLIOTIS D STEINMETZ HT SCHWONZEN M WICKRAMANAYAKE PD DIEHL V
Citation: P. Staib et al., CYTOSINE-ARABINOSIDE, ETOPOSIDE AND ACLARUBICIN (AVA) FOR THE TREATMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN ELDERLY PATIENTS, Annals of oncology, 9(2), 1998, pp. 221-223
TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA USING IMMUNOTHERAPY WITH INTERLEUKIN-2
Authors: VOLIOTIS DL SCHMITZ S STAIB P VONBERGWELTBAILDON M TESCH H DIEHL V
Citation: Dl. Voliotis et al., TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA USING IMMUNOTHERAPY WITH INTERLEUKIN-2, Blood, 90(10), 1997, pp. 3857-3857
COMPLEX CHROMOSOME-ABERRATIONS IN PATIENTS WITH DE-NOVO AML ARE ASSOCIATED WITH A VERY POOR-PROGNOSIS DESPITE INTENSIVE TREATMENT - A STUDYOF 90 PATIENTS
Authors: SCHOCH C HAFERLACH T HAASE D FONATSCH C SCHLEGELBERGER B SAUERLAND MC LOFFLER H STAIB P WORMANN B BUCHNER T HIDDEMANN W
Citation: C. Schoch et al., COMPLEX CHROMOSOME-ABERRATIONS IN PATIENTS WITH DE-NOVO AML ARE ASSOCIATED WITH A VERY POOR-PROGNOSIS DESPITE INTENSIVE TREATMENT - A STUDYOF 90 PATIENTS, Blood, 90(10), 1997, pp. 272-272
EFFECTS OF HIGH-DOSE CYTARABIN (HD-ARA-C) AS PART OF DOUBLE INDUCTIONSTRATEGY IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) AND RESULTS OF COMBINATION WITH ALL-TRANS-RETINOIC ACID (ATRA)
Authors: LENGFELDER E REICHERT A HEHLMANN R LOFFLER H FONATSCH C SCHOCH C STAIB P SEIFARTH W SAUERLAND MC HEINECKE A WORMANN B HIDDEMANN W BUCHNER T
Citation: E. Lengfelder et al., EFFECTS OF HIGH-DOSE CYTARABIN (HD-ARA-C) AS PART OF DOUBLE INDUCTIONSTRATEGY IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) AND RESULTS OF COMBINATION WITH ALL-TRANS-RETINOIC ACID (ATRA), Blood, 90(10), 1997, pp. 1475-1475
PROGNOSTIC RELEVANCE OF CYTOGENETIC SUBGROUPS IN 357 PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: HAASE D SCHANZ J WULICH J SCHOCH C FREUND M HAFERLACH T WORMANN B STAIB P LENTINI G BARTELS H GEISSLER RG GERMING U DORGES U FONATSCH C HIDDEMANN W
Citation: D. Haase et al., PROGNOSTIC RELEVANCE OF CYTOGENETIC SUBGROUPS IN 357 PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 90(10), 1997, pp. 2232-2232
PROGNOSTIC RELEVANCE OF PRETHERAPEUTIC IN-VITRO CHEMOSENSITIVITY TESTING IN ADULT AML
Authors: STAIB P LATHAN B MICHEL K JANZ E SCHINKOTHE T DIEHL V
Citation: P. Staib et al., PROGNOSTIC RELEVANCE OF PRETHERAPEUTIC IN-VITRO CHEMOSENSITIVITY TESTING IN ADULT AML, Blood, 88(10), 1996, pp. 1447-1447
PHASE-II TRIAL OF IDARUBICIN, FLUDARABINE, ARA-C, AND FILGRASTIM FILGRASTIM (G-CSF) (IDA-FLAG) FOR TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA (AML)
Authors: WICKRAMANAYAKE PD STEINMETZ HT KATAY I GLASMACHER A STAIB P DIEHL V
Citation: Pd. Wickramanayake et al., PHASE-II TRIAL OF IDARUBICIN, FLUDARABINE, ARA-C, AND FILGRASTIM FILGRASTIM (G-CSF) (IDA-FLAG) FOR TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA (AML), Blood, 86(10), 1995, pp. 3009-3009
ESTROGEN FORMATION IN GENITAL AND NON-GENITAL SKIN FIBROBLASTS CULTURED FROM PATIENTS WITH HYPOSPADIAS
Authors: STAIB P KAU N ROMALO G SCHWEIKERT HU
Citation: P. Staib et al., ESTROGEN FORMATION IN GENITAL AND NON-GENITAL SKIN FIBROBLASTS CULTURED FROM PATIENTS WITH HYPOSPADIAS, Clinical endocrinology, 41(2), 1994, pp. 237-243
PHASE-II TRIAL OF IDARUBICIN, FLUDARABINE, CYTIDINE ARABINOSIDE (ARA-C), AND FILGRASTIM (G-CSF) (IDA-FLAG) FOR TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA (AML)
Authors: WICKRAMANAVAKE PD STEINMETZ HT KATAY I GLASMACHER A NEUFANG A STAIB P SCHWONZEN M DIEHL V
Citation: Pd. Wickramanavake et al., PHASE-II TRIAL OF IDARUBICIN, FLUDARABINE, CYTIDINE ARABINOSIDE (ARA-C), AND FILGRASTIM (G-CSF) (IDA-FLAG) FOR TREATMENT OF POOR-PROGNOSIS ACUTE MYELOID-LEUKEMIA (AML), Blood, 84(10), 1994, pp. 10000618-10000618
Risultati: 1-9 |